Skip to main content
. 2013 Aug 23;1(3):166–183. doi: 10.1093/gastro/got022

Table I.

Biomarkers used in clinical practice

Biomarkers Clinical use
KRAS Identification of resistance to anti-EGFR moAB in metastatic CRC patients
BRAF Identification of resistance to anti-EGFR moAB in metastatic CRC patients.
Exclusion of Lynch Syndrome
MSI Identification of Lynch Syndrome
Oncotype DX colon cancer assay Inform treatment planning in stage II and II colorectal cancer patients

Abbreviations: MSI = microsatellite instability.

HHS Vulnerability Disclosure